TherapeuticsMD, Inc. (TXMD): Operating Income
-$4.39M
Year ended 2025-12-31
-$3.95M
Trailing 12 months to 2026-06-30
| Period ended | Operating Income | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | -$4.39M | n/m | 2026-04-01, From 2025-01-01 |
| 2024-12-31 | -$6.11M | n/c | 2026-04-01, From 2024-01-01 |
| 2023-12-31 | -$8.52M | n/m | 2025-03-27, From 2023-01-01 |
| 2022-12-31 | $1.19M | n/m | 2024-03-29, From 2022-01-01 |
| 2021-12-31 | -$79.58M | n/c | 2023-04-07, From 2021-01-01 |
| 2020-12-31 | -$155.54M | n/m | 2022-03-23, From 2020-01-01 |
| 2019-12-31 | -$151.21M | n/m | 2022-03-23, From 2019-01-01 |
| 2018-12-31 | -$130.22M | n/m | 2021-03-04, From 2018-01-01 |
| 2017-12-31 | -$77.63M | n/m | 2020-02-24, From 2017-01-01 |
| 2016-12-31 | -$90.25M | n/m | 2019-02-27, From 2016-01-01 |
| 2015-12-31 | -$85.19M | n/m | 2018-02-23, From 2015-01-01 |
| 2014-12-31 | -$54.04M | n/m | 2017-02-28, From 2014-01-01 |
| 2013-12-31 | -$25.81M | n/m | 2016-02-26, From 2013-01-01 |
| 2012-12-31 | -$16.15M | n/m | 2015-03-12, From 2012-01-01 |
| 2011-12-31 | -$5.43M | n/a | 2014-03-05, From 2011-01-01 |
Operating Income at similar companies
| Company | Year ended | Operating Income | Change YoY |
|---|---|---|---|
| TherapeuticsMD, Inc. (TXMD) | 2025-12-31 | -$4.39M | n/m |
| Xenetic Biosciences, Inc. (XBIO) | 2025-12-31 | -$2.83M | n/m |
| Upstream Bio, Inc. (UPB) | 2025-12-31 | -$160.36M | n/m |
| Cartesian Therapeutics, Inc. (RNAC) | 2025-12-31 | -$143.41M | n/m |
| Camp4 Therapeutics Corp (CAMP) | 2025-12-31 | -$52.55M | n/m |
| Marker Therapeutics, Inc. (MRKR) | 2025-12-31 | -$12.89M | n/m |
| GeoVax Labs, Inc. (GOVX) | 2025-12-31 | -$21.64M | n/m |
| CervoMed Inc. (CRVO) | 2025-12-31 | -$28.29M | n/m |
| China Pharma Holdings, Inc. (CPHI) | 2025-12-31 | -$3.24M | n/m |
Compare TXMD, XBIO, UPB, RNAC side by side · Screen every company in Pharmaceutical Preparations ↗